Pharmacology of diabetes 2 Flashcards

1
Q

Name two other types of diabetes outside type 1 & 2

A

Latent Autoimmune diabetes (adults)
Maturity Onset diabetes (young)
Gestational Diabetes (during pregnancy)
Steroid Induced diabetes (glucocorticoids elevate glucose)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is LADA?

A
  • autoimmune disease affecting beta cells
  • onset adulthood
  • don’t have to have elevated BMI which see in most type 2
  • will lose weight and be non-responsive to medications
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is MODY?

A
  • Rare genetic diabetes

- may not need insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the diagnostic criteria for Type 1?

A
  • rapid weight loss
  • BMI <25
  • possibly DKA
  • no autoimmune disease present
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the diagnostic criteria for Type 2?

A
  • HbA1c > 48 mmol/mol must be taken at least twice (3 month apart)
  • Fasting glucose > 7 mmol/L
  • Random plasma glucose >11.1 mmol/L
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is HbA1c?

A
  • glycosylated Haemoglobin
  • Testing for the sugar present on the surface of the haemoglobin molecules
  • if in sugary blood will have higher levels
  • Higher the HbA1c the greater the risk of complications
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

When can HbA1c not be used?

A
  • Not used in type 1
  • Can also be less sensitive then fasting blood glucose levels even in Type 2
  • If anaemic or pregnant where high RBC turnover can’t be used
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What should the target HbA1c be?

A
  • changes between individuals usually between (48-53 mmol/mol and 6.5%)
  • may end up being above the 48 mmol/mol used in diagnosis
  • advice that the lower they get there HbA1c the lower there risk for complications (any reduction will help)
  • Avoid suggesting highly intensive management levels try and bring it down gradually (otherwise may cause hypoglycaemia)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the different treatments used in control of type 2 diabetes?

A
  • Education
  • Lifestyle (stop smoking + drinking)
  • Control BP
  • Metformin (control glucose)
  • Statin (lower lipids)
  • Aspirin (anti-platelet to reduce macro/microvascular disease)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the non-pharmacological managements of diabetes?

A
  • Education (educational groups online)
  • Diet (dietician, diet sheets)
  • Lifestyle (increase exercise and weight loss)
  • Foot care (diabetic neuropathy)
  • Retinal photography (prevent diabetic retinopathy)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What diabetes complications should be looked out for?

A
Kidneys
Neuropathy
Infections
Vascular
Eyes
Skin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the different drug treatments in diabetes?

A
  • Biguanide
  • Sulfonylureas
  • Glucagon like peptide
  • Dipeptidylpeptidase IV inhibitors
  • Na/Glucose Co-transport 2-inhibitors
  • Thiazolidinesdiones
  • Meglitinides
  • aGlucosidase inhibitors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Example of Biguanides?

A

Metformin (only one in the class)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Example of Sulfonylureas?

A

Gliclazide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Example of Glucagon like peptides?

A

Liraglutide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Example of Dipeptidylpeptidase IV inhibitors?

A

sitagliptin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Example of sodium glucose co-transport 2-inhibitors?

A

dapagliflozin

18
Q

Example of Thiazolidinedione?

A

pioglitazone

19
Q

Example of Meglitinides?

A

repaglinide

20
Q

Example of alpha glucose inhibitors?

21
Q

What is the first treatment tried to get HbA1c down?

A

1) Lifestyle mesures

22
Q

What is the first line drug treatment for type 2 diabetes?

A

Monotherapy Metformin

23
Q

What is currently second line treatment for diabetes?

A
  • SGLT2 inhibitors (sodium glucose transport proteins)
    OR
  • GLP-1RA (glucagon-like peptide-1 receptor agonist)
24
Q

When should SGLT2 inhibitors or GLP-1RA be preferentially used?

A

SGLT2 inhibitors = CKD
GLP-1RA = high risk CVD
SGLT2 inhibitors cautioned in those with neuropathic feet problems as increased risk of amputation so use GLP-1RA

25
What is the MoA of Metformin?
- activates liver AMP-kinase reducing glucose output from the liver - increases liver, muscle and fat cell sensitivity to insulin - enhances glucose peripheral uptake and utilisation
26
What are side effects of metformin/biguanide?
- Causes weight loss (may be useful) - GI adverse effects e.g. nausea, diarrhoea and flatulence - Unlikely to cause hypoglycaemia as enhances natural insulin signal - Lactic acidosis (very rare) only seen in whose with CKD already
27
How can side effects be prevented?
- Start on low dose then increase over period of weeks - Take with meals - If struggling to take pill give modified release preparation - Can damage kidneys so use with caution in those with renal damage check U&Es
28
Why should Metformin be stopped?
If serum creatinine above 150 micro mol/L or eGFR < 30mL/min/1.73m(squared)
29
What is the MoA of sulfonylureas?
- sulfonylurea binds to sulfonylurea receptor of pancreatic Beta cell - this closes ATP-K channels - less potassium leaves the cell - increase in calcium influx - beta cell depolarises and insulin is released
30
When is sulfonylurea used/not used?
- used less now used to be second line treatment - patients need to have functioning beta cells - antagonised by corticosteroids and thiazide-like diuretics
31
Side effects of Sulfonylurea?
- prolonged hypoglycaemia (bypass natural negative feedback loop so insulin constantly secreted) - weight gain - hyponatraemia - oedema - Hepatotoxicity - photosensitivity - allergy/rash
32
How do incretin effects differ in healthy and diabetic patients?
Diabetes: incretin signal reduced so less insulin secreted healthy: after meal get activity of incretin group which promotes insulin signal
33
What are the incretin hormones?
1) GLP-1 (Glucagon like peptide)
34
Where is GLP-1 released from and what stimulates release?
- L-cells in small intestines | - Stimulated by lipids and carbohydrates
35
What is MoA of GLP-1?
- Binds to G-protein coupled receptors on beta cells which stimulates insulin secretion - also stimulates B cell growth - insulin synthesis - inhibits glucagon secretion - decreases hepatic glucose output and gastric emptying - promotes satiety
36
What enzyme degrades GLP-1?
Dipeptidyl peptidase IV
37
What are the two drug types acting on the GLP-1 mechanism?
1) incretin mimetics Glucagon like peptides (analogues of GLP-1 which take longer to breakdown) 2) Incretin Enhancers (inhibitors of dipeptidyl Peptidase IV, keep natural GLP-1 levels larger for longer)
38
Why can GLP-1 analogues be disliked?
- Injection whereas tablets would be more convenient - causes GI disturbance (nausea and vomiting) - slight increase in pancreatitis risk and pancreatic cancer
39
Side effects of GLP-1 analogues?
- causes GI disturbance (nausea and vomiting) - causes weight loss - can cause Hypoglycaemia - slight increase in pancreatitis risk and pancreatic cancer - caution in renal disease - Delays gastric emptying so contraindicated in people with gastroparesis
40
What are the advantages and disadvantages of using DPPIV inhibitors over GLP-1 analogues?
- Tablet form - slight increased risk of hypoglycaemia - don't help in weight loss
41
Adverse effects of DPPIV inhibitors?
- nasopharyngitis - headache, nausea - possible risk of heart failure
42
What should be checked after 6 months of use of either incretin hormones?
HbA1c checked In GLP-1 if not decreased by 1% than stopped or If weight not decreased by more than 3% than stopped In DPPIV if not degreased by more than 0.5% stopped